Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Redhill Biophrma ADR (RDHL)

Redhill Biophrma ADR (RDHL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,763
  • Shares Outstanding, K 52,684
  • Annual Sales, $ 85,760 K
  • Annual Income, $ -97,740 K
  • 60-Month Beta 1.94
  • Price/Sales 0.31
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RDHL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.26
  • Most Recent Earnings -0.30 on 06/23/22
  • Next Earnings Date 10/06/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 423.02% ( -470.11%)
  • Historical Volatility 91.28%
  • IV Percentile 82%
  • IV Rank 27.03%
  • IV High 1,330.20% on 05/12/22
  • IV Low 87.02% on 11/18/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 49
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 6,121
  • Open Int (30-Day) 5,876

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.30
  • Number of Estimates 1
  • High Estimate -0.30
  • Low Estimate -0.30
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +34.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4726 +12.12%
on 09/23/22
0.9000 -41.12%
on 09/09/22
-0.3367 (-38.85%)
since 09/02/22
3-Month
0.4726 +12.12%
on 09/23/22
1.2300 -56.92%
on 07/11/22
-0.3117 (-37.04%)
since 07/01/22
52-Week
0.4726 +12.12%
on 09/23/22
6.5000 -91.85%
on 10/21/21
-4.3501 (-89.14%)
since 10/04/21

Most Recent Stories

More News
RedHill's Oral Broad-Acting Antivirals, Opaganib and RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5

Novel, oral, host-targeted, broad-acting antivirals, once-daily RHB-107 (upamostat) and twice-daily opaganib, demonstrated in vitro inhibition of the...

RDHL : 0.5279 (+3.92%)
RedHill (RDHL) Up on Orphan Drug Tag for NTM Disease Drug

RedHill's (RDHL) RHB-204 gets Orphan Drug designation from the European Commission for the treatment of nontuberculous mycobacteria (NTM) disease

JAZZ : 136.99 (+1.14%)
RDHL : 0.5279 (+3.92%)
SLNO : 1.7750 (+2.01%)
AQST : 1.1550 (-2.12%)
RedHill Announces New H. pylori and COVID-19 Data Publication and Presentations at Leading Upcoming Scientific Conferences

Talicia® - World Gastro 2022 congress (August 17-18): RedHill invited to give prestigious oral presentation of important data detailing high eradication rates...

RDHL : 0.5279 (+3.92%)
RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22

Targeting positive cash from operations to start during H2/22[1] Focus on earlier achievement of operational profitability thanks to a recently implemented...

RDHL : 0.5279 (+3.92%)
RedHill Biopharma to Host First Quarter 2022 Financial Results and Operational Highlights Webcast on June 23, 2022

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will report...

RDHL : 0.5279 (+3.92%)
Redhill Biopharma Ltd. (RDHL) Could Find Support Soon, Here's Why You Should Buy the Stock Now

Redhill Biopharma Ltd. (RDHL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement...

RDHL : 0.5279 (+3.92%)
RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib

Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The...

RDHL : 0.5279 (+3.92%)
RedHill Announces Additional Insider Buying

RALEIGH, NC and TEL-AVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that members...

RDHL : 0.5279 (+3.92%)
RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori

RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication Despite increasing...

RDHL : 0.5279 (+3.92%)
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant

Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s...

BIOV.CN : 0.105 (-12.50%)
BVAXF : 0.0923 (+22.90%)
GSK : 30.66 (+1.36%)
JNJ : 164.75 (+0.95%)
SRNE : 1.5800 (+1.94%)
RDHL : 0.5279 (+3.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating...

See More

Key Turning Points

3rd Resistance Point 0.6075
2nd Resistance Point 0.5787
1st Resistance Point 0.5434
Last Price 0.5279
1st Support Level 0.4793
2nd Support Level 0.4505
3rd Support Level 0.4152

See More

52-Week High 6.5000
Fibonacci 61.8% 4.1975
Fibonacci 50% 3.4863
Fibonacci 38.2% 2.7751
Last Price 0.5279
52-Week Low 0.4726

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar